RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
Go back to RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.65 | 52 Week High | $16.54 | |||
| Open | $0.65 | 52 Week Low | $8.10 | |||
| Day High | $0.65 | P/E | N/A | |||
| Day Low | $0.65 | EPS | $0.00 | |||
| Volume | 48,258 | |||||
